RECURSION PHARMACEUTICALS-A

$17.77 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About RECURSION PHARMACEUTICALS-A

Recursion Pharmaceuticals, Inc. operates as a bio-technology company. The Company combines artificial intelligence with automation to conduct experimental biology for testing compounds of cellular disease models in parallel. Recursion Pharmaceuticals serves customers worldwide.

Stock Analysis

last close $17.77
1-mo return -27.2%
3-mo return -50.6%
avg daily vol. 799.42T
52-week high 42.81
52-week low 16.5
market cap. $3.0B
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $4M
inst own. 71.6%
baraka

Subscribe now for daily local and international financial news

Subscribe